Overview

Efficacy of Topical 95% TCA in the Treatment of CIN 1 or Less After Low-grade Abnormality of Screening Test

Status:
Withdrawn
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy of topical 95% TCA in the treatment of CIN 1 or less after low grade abnormality of screening test
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Rajavithi Hospital
Treatments:
Acetic Acid